Tumor necrosis factor alpha modulates the dynamics of the plasminogen-mediated early interaction between Bifidobacterium animalis subsp. lactis and human enterocytes

Applied and Environmental Microbiology

Volumn 78, Issue 7, 2012, Pages 2465-2469

  Centanni, Manuela ^a   Bergmann, Simone ^b   Turroni, Silvia ^a   Hammerschmidt, Sven ^c   Chhatwal, Gursharan Singh ^d   Brigidi, Patrizia ^a   Candela, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

BACTERIUM ADHERENCE; BIFIDOBACTERIUM; CELL STRAIN HT29; HUMAN; INTESTINE CELL; METABOLISM; MICROBIOLOGY; NOTE; PHYSIOLOGY;

BACTERIAL ADHESION; BIFIDOBACTERIUM; ENTEROCYTES; HT29 CELLS; HUMANS; PLASMINOGEN; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS;

EID: 84861125647     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.07883-11     Document Type: Note

References (41)

1. Antikainen J, Kuparinen V, Lähteenmäki K, Korhonen TK. 2007. Enolases from Gram-positive bacterial pathogens and commensal lactobacilli share functional similarity in virulence-associated traits. FEMS Immunol. Med. Microbiol. 51:526 -534.
2. Attali C, Durmort C, Vernet T, Di Guilmi AM. 2008. The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect. Immun. 76:5350 -5356.
3. Barrangou R, et al. 2009. Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. J. Bacteriol. 191:4144-4151.
4. Bergmann S, et al. 2009. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J. Cell Sci. 122:256 -267.
5. Bergmann S, Hammerschmidt S. 2007. Fibrinolysis and host response in bacterial infections. Thromb. Haemost. 98:512-520.
6. Blaser MJ, Kirschner D. 2007. The equilibria that allow bacterial persistence in human hosts. Nature 449:843- 849.
7. Candela M, et al. 2008. Plasminogen-dependent proteolytic activity in Bifidobacterium lactis. Microbiology 154:2457-2462.
8. Candela M, et al. 2007. Binding of human plasminogen to Bifidobacterium. J. Bacteriol. 189:5929 -5936.
9. Candela M, et al. 2005. Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Res. Microbiol. 156:887- 895.
10. Ertongur S, et al. 2004. Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system. Int. J. Cancer 110:815- 824.
11. Gilad O, Svensson B, Viborg AH, Stuer-Lauridsen B, Jacobsen S. 2011. The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative roles in probiotic effects. Proteomics 11: 2503-2514.
12. Gill SR, et al. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-1359.
13. Hess DJ, Henry-Stanley MJ, Erickson EA, Wells CL. 2002. Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions. J. Surg. Res. 104:88 -94.
14. Killeen SD, Wang JH, Andrews EJ, Redmond HP. 2009. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br. J. Cancer 100:1589 -1602.
15. Kinnby B, Booth NA, Svensäter G. 2008. Plasminogen binding by oral streptococci from dental plaque and inflammatory lesions. Microbiology 154:924 -931.
16. Lähteenmäki K, Edelman S, Korhonen TK. 2005. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 13: 79-85.
17. Ley RE, et al. 2008. Evolution of mammals and their gut microbes. Science 320:1647-1651.
18. Ma TY, et al. 2004. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G367-G376.
19. Meile L, et al. 1997. Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst. Appl. Microbiol. 20: 57-64.
20. Mondino A, Blasi F. 2004. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25:450-455.
21. Ochman H, Lawrence JG, Groisman EA. 2000. Lateral gene transfer and the nature of bacterial innovation. Nature 405:299 -304.
22. O'Hara AM, et al. 2006. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118:202-215.
23. Okumura S, et al. 2008. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cellrecruiting molecules via NOD2 in mast cells. Clin. Immunol. 130:175- 185.
24. Pancholi V, Fontan P, Jin H. 2003. Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells. Microb. Pathog. 35:293-303.
25. Parkkinen J, Korhonen TK. 1989. Binding of plasminogen to Escherichia coli adhesion proteins. FEBS Lett. 250:437- 440.
26. Rousset M. 1986. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 68:1035-1040.
27. Saksela O, Rifkin DB. 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4:93-126.
28. Sánchez B, Bressollier P, Urdaci MC. 2008. Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host. FEMS Immunol. Med. Microbiol. 54:1-17.
29. Schaumburg J, et al. 2004. The cell wall subproteome of Listeria monocytogenes. Proteomics 4:2991-3006.
30. Sebbane F, Jarrett O, Gardner D, Long D, Hinnebusch BJ. 2006. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc. Natl. Acad. Sci. U. S. A. 103:5526 -5530.
31. Setyono-Han B, et al. 2005. Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1. Thromb. Haemost. 93:779 -786.
32. Sijbrandi R, et al. 2005. Characterization of an iron-regulated alphaenolase of Bacteroides fragilis. Microbes Infect. 7:9 -18.
33. Sokol H, et al. 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15:1183-1189.
34. Stecher B, Hardt WD. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16:107-114.
35. Steinert M, Hentschel U, Hacker J. 2000. Symbiosis and pathogenesis: evolution of the microbe-host interaction. Naturwissenschaften 87:1-11.
36. Sun H. 2005. The interaction between pathogens and host coagulation system. Physiology 21:281-288.
37. Sun H, et al. 2004. Plasminogen is a critical factor for group A streptococcal infection. Science 305:1283-1286.
38. Turroni F, et al. 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75:1534-1545.
39. Veiga P, et al. 2010. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. U. S. A. 107:18132-18137.
40. Yan Y, et al. 2008. Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation. Am. J. Pathol. 173:1013-1028.
41. Zhang L, et al. 2002. Plasminogen has a broad extrahepatic distribution. Thromb. Haemost. 87:493-501.